Two-year outcomes of intravitreal ziv-aflibercept

AimTo assess the two-year outcome of intravitreal ziv-aflibercept (IVZ) in eyes with macular diseases.MethodsConsecutive subjects with various macular diseases that received six or more of 0.05 mL IVZ (1.25 mg) injections with at least 1 year follow-up were included. Outcome measures were best-corre...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of ophthalmology 2018-10, Vol.102 (10), p.1387-1390
Hauptverfasser:	Mansour, Ahmad M, Ashraf, Mohammed, Charbaji, Abdulrazzak, Younis, Muhammad H, Souka, Ahmed A, Dogra, Avantika, Mansour, Hana A, Chhablani, Jay
Format:	Artikel
Sprache:	eng
Schlagworte:	Age Cardiovascular disease Cataracts Collaboration Coronary vessels Diabetes Diabetic retinopathy Edema FDA approval Hypertension Macular degeneration Ophthalmology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!